GENE EDITING USING MODIFIED CLOSED-END DNA (ceDNA) Russian patent published in 2024 - IPC C12N5/10 C12N15/09 C12N15/63 C12N15/64 

Abstract RU 2811724 C2

FIELD: biotechnology; genetic engineering.

SUBSTANCE: invention is a method of inserting a donor sequence into a predetermined insertion site on a chromosome in a host cell, comprising: introducing a guide RNA (gRNA) and an mRNA encoding a Cas enzyme into the host cell; and a composition comprising a lipid nanoparticle (LNP) containing a capsid-less closed-end DNA vector (ceDNA); wherein the ceDNA vector contains a nucleotide sequence between flanking inverted terminal repeats (ITR), wherein at least one nucleotide sequence is a gene-editing nucleic acid sequence containing a 5'-homologous arm, a repair template donor sequence and a 3'-homologous arm, and wherein the donor sequence is inserted into the chromosome at or near said insertion site by homologous recombination. The invention also relates to a method for editing chromosomal genes in a host cell, including introducing into the host cell a guide RNA (gRNA) and an mRNA encoding the Cas enzyme; and a composition comprising a lipid nanoparticle (LNP) containing a capsid-less closed-end DNA vector (ceDNA); wherein the ceDNA vector contains a nucleotide sequence between flanking inverted terminal repeats (ITRs), wherein at least one nucleotide sequence is a gene-editing nucleic acid sequence, wherein the gene-editing nucleic acid sequence contains a donor sequence, wherein said chromosome is restored using non-homologous end joining (NHEJ).

EFFECT: invention makes it possible to effectively insert a donor sequence into a certain part of the host cell chromosome.

62 cl, 19 dwg, 10 tbl, 18 ex

Similar patents RU2811724C2

Title Year Author Number
MODIFIED CLOSED CIRCULAR DNA (CCDNA) CONTAINING SYMMETRIC MODIFIED INVERTED END REPEATED SEQUENCES 2019
  • Kotin, Robert Majkl
  • Alkan, Ozan
  • Dzhons, Annalize
RU2816963C2
MODIFIED CLOSED-ENDED DNA (scDNA) 2018
  • Kotin, Robert Majkl
  • Alkan, Ozan
  • Dzhons, Annalize
  • Kerr, Duglas Entoni
  • Malakian, Ara Karl
  • Simmons, Metyu Dzhon
  • Rajt, Tereza L.
RU2800026C2
CLOSED-ENDED DNA VECTORS OBTAINED BY CELL-FREE SYNTHESIS, AND METHOD OF PRODUCING CEDNA VECTORS 2019
  • Alkan, Ozan
  • Kotin, Robert Majkl
  • Stanton, Metyu
  • Kerr, Duglas Entoni
  • Pelleter, Karolin
RU2820586C2
MODULATION OF REP PROTEIN ACTIVITY WHEN PRODUCING CLOSED-END DNA (ceDNA) 2020
  • Kotin, Robert, Majkl
  • Ucher, Anna
  • Malakyan, Ara, Karl
RU2812850C2
NON-VIRAL DNA VECTORS AND OPTIONS FOR THEIR USE FOR EXPRESSION OF THERAPEUTIC AGENT BASED ON PHENYLALANINE HYDROXYLASE (PAH) 2020
  • Kerr, Duglas Antoni
  • Samajoa, Fillip
  • Silver, Nataniel
  • Chiokko, Mettyu
RU2814137C2
NON-VIRAL DNA VECTORS AND THEIR USE FOR THE PRODUCTION OF ANTIBODIES AND FUSION PROTEINS 2019
  • Alkan, Ozan
  • Kerr, Duglas Entoni
  • Kotin, Robert Majkl
  • Klatte, Debra
  • Liu, Lea
  • Silver, Nataniel
RU2800914C2
CLOSED-END LINEAR DUPLEX DNA FOR NON-VIRAL GENE TRANSFER 2017
  • Kotin, Robert, M.
  • Sekkini, Silvejn
RU2752882C2
NON-VIRAL DNA VECTORS AND OPTIONS FOR THEIR USE FOR EXPRESSION OF THERAPEUTIC AGENT BASED ON FACTOR VIII (FVIII) 2020
  • Kerr, Duglas, Antoni
  • Klatte, Debra
  • Samajoa, Fillip
  • Silver, Nataniel
RU2812852C2
CONTROLLED EXPRESSION OF TRANSGENES USING CLOSED-END DNA VECTORS (ceDNA) 2019
  • Kerr, Duglas A.
  • Stanton, Metyu Dzh.
  • Chiokko, Mett
  • Angelino, Mark D.
  • Kotin, Robert M.
  • Samajoa, Fillip
RU2816871C2
TRANSGENIC ANIMALS AND TRANSGENIC EMBRYOS PRODUCING ENGINEERED NUCLEASE 2019
  • Jang, Goo
  • Yum, Soo Young
  • Gim, Gyeong Min
  • Lee, Won You
  • Park, Ji Hyun
RU2817017C2

RU 2 811 724 C2

Authors

Kotin, Robert Majkl

Kerr, Duglas

Samajoa, Fillip

Alkan, Ozan

Simmons, Mettyu Dzh.

Dates

2024-01-16Published

2018-12-06Filed